Market Overview

Edwards Lifesciences Confirms Appeals Court Ruling of Medtronic's Willful Infringement of Transcatheter Valve Patent

Related EW
Stocks Hitting 52-Week Highs
Stocks Hitting 52-Week Highs
Making Money With Charles Payne: 10/10/14 (Fox Business)
Related MDT
Medtronics Reports FDA Approval Of Capsurefix Novus MRI Surescane 5076 Full-Body Scanners
Medtronic Announces Commencement of Pivotal Study of First Predictive Low Glucose Mgmt Technology for People with Diabetes
JPM Denies Report of Second Hack Attack (Fox Business)

Edwards Lifesciences Corporation (NYSE: EW) announced that the U.S. Court of Appeals for the Federal Circuit today affirmed an April 2010 federal jury decision that Medtronic (NYSE: MDT) CoreValve LLC is willfully infringing Edwards' U.S. Andersen transcatheter heart valve patent. The Appeals Court also ordered the trial court to reconsider Edwards' request for a permanent injunction that would prohibit the manufacture and sale of the CoreValve System in the United States. In addition, the Court affirmed the validity of this patent and the federal jury's verdict awarding an initial payment of $74 million in damages to Edwards, which covers infringement through early 2010.

Posted-In: News Legal

 

Related Articles (EW + MDT)

Around the Web, We're Loving...

Get Benzinga's Newsletters